title: Psychiatric disorders in children and adolescents who have epilepsy.
authors.affiliation: Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, USA.
authors.forename: Jana E
authors.initials: JE
authors.lastname: Jones
authors.forename: Joan K
authors.initials: JK
authors.lastname: Austin
authors.forename: Rochelle
authors.initials: R
authors.lastname: Caplan
authors.forename: David
authors.initials: D
authors.lastname: Dunn
authors.forename: Sigita
authors.initials: S
authors.lastname: Plioplys
authors.forename: Jay A
authors.initials: JA
authors.lastname: Salpekar
mesh_terms: D000293:Adolescent; D001008:Anxiety Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D042241:Early Diagnosis; D004827:Epilepsy / Q000453:epidemiology* / Q000209:etiology / Q000523:psychology; D006306:Health Surveys; D006801:Humans; D008403:Mass Screening; D001523:Mental Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use
chemical_list: D011619:Psychotropic Drugs